The U.S. Food and Drug Administration has approved the first new tuberculosis drug in 25 years. The FDA said that it has approved rifapentine, which is marketed under the name Priftin by Hoechst Marion Roussell Inc. of Kansas City, Missouri. The U.S. is the first country to approve the drug.